Association of Primary Varicose Veins with Dysregulated Vein Wall Apoptosis

European Journal of Vascular and Endovascular Surgery

Volumn 35, Issue 2, 2008, Pages 224-229

  Ducasse, E ^a,b,c   Giannakakis, K ^c   Speziale, F ^b   Midy, D ^a   Sbarigia, E ^b   Baste, J C ^a   Faraggiana, T ^c  

^a HÔPITAL PELLEGRIN   (France)

^b POLICLINICO UMBERTO I   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Apoptosis; Mitochondrial pathway; Primary varicose veins; Varicose vein; Vascular apoptosis

Indexed keywords

CASPASE 8; CASPASE 9; FAS ANTIGEN; PEROXIDASE; PROTEIN BAX;

ADULT; APOPTOSIS; ARTERY BYPASS; ARTICLE; CELL COUNT; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDIATOR; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANK SUM TEST; RECURRENT DISEASE; REGULATORY MECHANISM; SAPHENOUS VEIN; VARICOSIS; VEIN WALL;

ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 8; CASPASE 9; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SAPHENOUS VEIN; TUNICA MEDIA; VARICOSE VEINS;

EID: 38549133973     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.08.015     Document Type: Article

References (29)

1. Asher E., Theresa J., Hingorani A., Gunduz Y., Mazzariol F., and Kallakuri S. Programmed cell death (Apoptosis) and its role in the pathogenesis of lower extremity varicose veins. Ann Chir Vasc 14 (2000) 24-30
2. Ascher E., Jacob T., Hingorani A., Tsemekhin B., and Gundunz Y. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. J Vasc Surg 33 (2001) 1080-1086
3. Bujan J., Jimenez-Cossio J.A., Jurado F., Gimeno M.J., Pascual G., Garcia-Honduvilla B., et al. Evaluation of the smooth muscle cell component and apoptosis in the vein wall. Histol Histopathol 15 (2000) 745-752
4. Urbanek T., Skop B., Wiaderkiewicz R., Wilczok T., Ziaja K., Lebda-Wyborny T., et al. Smooth muscle cell apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg 28 (2004) 600-611
5. Ducasse E., Giannakakis K., Chevalier J., Dasnoy D., Puppinck P., Speziale F., et al. Dysregulated apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg 29 (2005) 316-323
6. Saxena A., McMeekin J.D., and Thomson D.J. Expression of Bcl-x, Bcl-2, Bax and Bak in endarterectomy and atherectomy specimens. J Pathol 196 (2002) 335-342
7. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., et al. Human ICE/CED-3 protease nomenclature. Cell 87 (1996) 171
8. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17 (1999) 331-367
9. Yuan J. Transducing signals of life and death. Curr Opin Cell Biol 9 (1997) 247-251
10. Reed J.C. Cytochrome c: can't live with it; can't live without it. Cell 91 (1997) 559-562
11. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
12. Ducasse E, Giannakakis K, Speziale F, Fiorani P, Sassoust G, Midy D et al. Superficial venous insufficiency: new data. Ann Vasc Surg in press.
13. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., and Oltvai Z.N. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4 (1993) 327-332
14. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
15. Diaz J.L., Oltersdorf T., Horne W., McConnel M., Wilson G., Weeks S., et al. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members. J Biol Chem 272 (1997) 11350-11355
16. Villa P., Kaufmann S.H., and Earnshaw W.C. Caspases and caspase inhibitors. Trends Biochem Sci 22 (1997) 388-393
17. Kockx M.M., Knaapen M.W., Bortier H.E., Cromheeke K.M., Boutherin T., Falson O., et al. Vascular remodeling in varicose veins. Angiology 49 (1998) 871-877
18. Roy N., Mahadevan M.S., McLean M., Shutler G., Yaraghi Z., Farahani R., et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80 (1995) 167-178
19. Fisher G.H., Rosenberg F.J., Strauss S.E., Dale J.K., Middelton L.A., Lin A.Y., et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81 (1995) 935-946
20. Reed J.C., Miyashita T., Takayama S., Wang H.G., Sato T., Krajewski S., et al. Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60 (1996) 23-32
21. Durand E., Mallat Z., Addad F., Vilde F., Desnos M., Guerot C., et al. Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol 39 (2002) 1680-1685
22. Mayr U., Mayr M., Li C., Wernig F., Dietrich H., Hu Y., et al. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res 90 (2002) 197-204
23. Jurokova Z., and Milenkov C. Ultrastructural evidence for collagen degradation in the walls of varicose veins. Exp Mol Pathol 37 (1982) 37-47
24. Pappas P.J., Gwertzman G.A., DeFouw D.O., Padberg Jr. F.T., Silva Jr. M.B., Duran W.N., et al. Retinoblastoma protein: a molecular regulator of chronic venous insufficiency. J Surg Res 76 (1998) 149-153
25. Zou H., Henzel W.J., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. Elegans CED-4, participates in cytochrome c-dependent activation of caspase 3. Cell 90 (1997) 405-413
26. Zou H., Li Y., Liu X., and Wang X. An Apaf-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase 9. J Biol Chem 274 (1999) 11549-11556
27. Saleh A., Srinivasula S., Acharya S., Fishel R., and Alnemri E. Cytochrome c and dATP-mediated oligomerization of Apaf-1is a prerequisite for procaspase-9 activation. J Biol Chem 274 (1999) 17941-17945
28. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9. Cell 94 (1998) 325-337
29. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., et al. Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 94 (1998) 339-352